In Russia, picamilon is marketed being a prescription drug. The rights to the drug belong to the Russian pharmaceutical business NPK ECHO ("НПК ЭХО"). It is far from approved for sale in the United States and has been considered an adulterating agent in dietary supplements,[6] with five American companies required https://andreiv580ehj7.dm-blog.com/profile